The Expression of CD90/Thy-1 in Hepatocellular Carcinoma: An In Vivo and In Vitro Study

Although the CD90 (Thy-1) was proposed as biomarker of several tumors and cancer stem cells, the involvement of this molecule in the progression of hepatocellular carcinoma (HCC) and other less frequent hepatic neoplasms is still undefined. The distribution of CD90 was investigated both in in vivo (...

Descripción completa

Detalles Bibliográficos
Autores principales: Sukowati, Caecilia Hapsari Ceriapuri, Anfuso, Beatrice, Torre, Giuliano, Francalanci, Paola, Crocè, Lory Saveria, Tiribelli, Claudio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3792890/
https://www.ncbi.nlm.nih.gov/pubmed/24116172
http://dx.doi.org/10.1371/journal.pone.0076830

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3792890/
https://www.ncbi.nlm.nih.gov/pubmed/24116172
http://dx.doi.org/10.1371/journal.pone.0076830

Ejemplares similares